{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:16:40Z","timestamp":1790522200862,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T00:00:00Z","timestamp":1636243200000},"content-version":"vor","delay-in-days":310,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001167","name":"Larry L Hillblom Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"ADDF","doi-asserted-by":"publisher","award":["20140901"],"award-info":[{"award-number":["20140901"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"ADDF","doi-asserted-by":"publisher","award":["2019A012SUP"],"award-info":[{"award-number":["2019A012SUP"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R005567\/1"],"award-info":[{"award-number":["MR\/R005567\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T033371\/1"],"award-info":[{"award-number":["MR\/T033371\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/20\/10397"],"award-info":[{"award-number":["PG\/20\/10397"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cerebral Circulation - Cognition and Behavior"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.cccb.2021.100033","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T13:10:04Z","timestamp":1636463404000},"page":"100033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["An introduction to therapeutic approaches to vascular cognitive impairment"],"prefix":"10.1016","volume":"2","author":[{"given":"Atticus H","family":"Hainsworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny M","family":"Elahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick A","family":"Corriveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cccb.2021.100033_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10571-016-0334-7","article-title":"The Science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline","volume":"36","author":"Corriveau","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"issue":"23","key":"10.1016\/j.cccb.2021.100033_bib0002","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1212\/WNL.0000000000004717","article-title":"Alzheimer's disease-related dementias summit 2016: national research priorities","volume":"89","author":"Corriveau","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.cccb.2021.100033_bib0003","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.cccb.2021.100033_bib0004","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jnnp.63.6.749","article-title":"Neuropathological assessment of the lesions of significance in vascular dementia","volume":"63","author":"Esiri","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.cccb.2021.100033_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-510X(02)00282-4","article-title":"The pathology of ischemic-vascular dementia: an update","volume":"203-204","author":"Jellinger","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cccb.2021.100033_bib0006","first-page":"14","article-title":"Post-mortem assessment in vascular dementia: advances and aspirations","author":"McAleese","year":"2016","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.cccb.2021.100033_bib0007","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1042\/CS20160607","article-title":"Clinical presentations and epidemiology of vascular dementia","volume":"131","author":"Smith","year":"2017","journal-title":"Clin. Sci."},{"issue":"5","key":"10.1016\/j.cccb.2021.100033_bib0008","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","article-title":"Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease","volume":"131","author":"Kalaria","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.cccb.2021.100033_bib0009","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1474-4422(02)00190-4","article-title":"Subcortical ischaemic vascular dementia","volume":"1","author":"Roman","year":"2002","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.cccb.2021.100033_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(03)00305-3","article-title":"Vascular cognitive impairment","volume":"2","author":"O'Brien","year":"2003","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.cccb.2021.100033_bib0011","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(08)70040-1","article-title":"Vascular cognitive impairment: current concepts and clinical developments","volume":"7","author":"Moorhouse","year":"2008","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.cccb.2021.100033_bib0012","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0271678X15621574","article-title":"Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals","volume":"37","author":"Ighodaro","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9314","key":"10.1016\/j.cccb.2021.100033_bib0013","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(02)08267-3","article-title":"Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial","volume":"359","author":"Erkinjuntti","year":"2002","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.cccb.2021.100033_bib0014","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","article-title":"Vascular cognitive impairment and dementia: JACC scientific expert panel","volume":"73","author":"Iadecola","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10004","key":"10.1016\/j.cccb.2021.100033_bib0015","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O'Brien","year":"2015","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.cccb.2021.100033_bib0016","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2004.09.014","article-title":"Treatment of vascular dementia: evidence from trials with non-cholinergic drugs","volume":"226","author":"Pantoni","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.cccb.2021.100033_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005568","article-title":"Therapeutic strategies and drug development for vascular cognitive impairment","volume":"6","author":"Smith","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.cccb.2021.100033_bib0018","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","volume":"27","author":"de Jager","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.cccb.2021.100033_bib0019","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-171042","article-title":"Homocysteine and dementia: an international consensus statement","volume":"62","author":"Smith","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.cccb.2021.100033_bib0020","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbadis.2015.11.015","article-title":"Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID)","volume":"1862","author":"Hainsworth","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.cccb.2021.100033_bib0021","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/2396987320920110","article-title":"Protocol: the lacunar intervention trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease","volume":"5","author":"Wardlaw","year":"2020","journal-title":"Eur. Stroke J."},{"issue":"4","key":"10.1016\/j.cccb.2021.100033_bib0022","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3233\/JAD-200759","article-title":"Alzheimer's Disease neuroimaging I. peripheral markers of vascular endothelial dysfunction show independent but additive relationships with brain-based biomarkers in association with functional impairment in Alzheimer's disease","volume":"80","author":"Drake","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.cccb.2021.100033_bib0023","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnins.2020.00084","article-title":"Hierarchical clustering analyses of plasma proteins in subjects with cardiovascular risk factors identify informative subsets based on differential levels of angiogenic and inflammatory biomarkers","volume":"14","author":"Winder","year":"2020","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.cccb.2021.100033_bib0024","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/brain\/awaa443","article-title":"Sleep deprivation impairs molecular clearance from the human brain","volume":"144","author":"Eide","year":"2021","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.cccb.2021.100033_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011104","article-title":"Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions","volume":"8","author":"Berry","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.cccb.2021.100033_bib0026","first-page":"I","article-title":"European stroke organisation and European academy of neurology joint guidelines on post-stroke cognitive impairment","volume":"6","author":"Quinn","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.cccb.2021.100033_bib0027","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.cccb.2021.100033_bib0028","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awz233","article-title":"Genome-wide association study of cerebral small vessel disease reveals established and novel loci","volume":"142","author":"Chung","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.cccb.2021.100033_bib0029","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-020-15932-3","article-title":"Genome-wide association study of MRI markers of cerebral small vessel disease in 42,310 participants","volume":"11","author":"Persyn","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cccb.2021.100033_bib0030","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41590-018-0232-x","article-title":"Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration","volume":"19","author":"Ryu","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cccb.2021.100033_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.721906","article-title":"Editorial: non-invasive brain stimulation in the study and modulation of metaplasticity in neurological disorders","volume":"12","author":"Cantone","year":"2021","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.cccb.2021.100033_bib0032","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/acn3.76","article-title":"Overcoming obstacles to repurposing for neurodegenerative disease","volume":"1","author":"Shineman","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.cccb.2021.100033_bib0033","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3233\/JAD-170101","article-title":"The rationale and design of the reducing pathology in Alzheimer's disease through angiotensin targeting (RADAR) trial","volume":"61","author":"Kehoe","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.cccb.2021.100033_bib0034","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-017-1973-9","article-title":"Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial","volume":"18","author":"Pauls","year":"2017","journal-title":"Trials"},{"issue":"20","key":"10.1016\/j.cccb.2021.100033_bib0035","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cccb.2021.100033_bib0036","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13195-021-00784-w","article-title":"Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?","volume":"13","author":"Femminella","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.cccb.2021.100033_bib0037","first-page":"e12053","volume":"12","author":"Carare","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.cccb.2021.100033_bib0038","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S2215-0366(21)00197-8","article-title":"The need to show minimum clinically important differences in Alzheimer's disease trials","volume":"8","author":"Liu","year":"2021","journal-title":"Lancet Psychiatry"}],"container-title":["Cerebral Circulation - Cognition and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666245021000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666245021000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:28:56Z","timestamp":1762979336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666245021000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":38,"alternative-id":["S2666245021000301"],"URL":"https:\/\/doi.org\/10.1016\/j.cccb.2021.100033","relation":{},"ISSN":["2666-2450"],"issn-type":[{"value":"2666-2450","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An introduction to therapeutic approaches to vascular cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Cerebral Circulation - Cognition and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cccb.2021.100033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100033"}}